Bayer CropSci.

  • Market Cap: Small Cap
  • Industry: Pesticides & Agrochemicals
  • ISIN: INE462A01022
  • NSEID: BAYERCROP
  • BSEID: 506285
INR
4,516.05
8.25 (0.18%)
BSENSE

Dec 05

BSE+NSE Vol: 5.86 k

  • Price Points
  • Score
  • Mojo Parameters
  • Total Return
  • News and Corporate Actions
  • Key factors
  • Shareholding
  • Financials
  • CompanyCV
stock-recommendationQuarterly Results
Results Snapshot
YoYQoQ
Figures in Cr
Standalone Quarterly Results
Sep'25
Jun'25
Mar'25
Dec'24
Sep'24
Jun'24
Mar'24
Quarterly Analysis Highlights - YoY
stock-summary

Net Sales

YoY Growth in quarter ended Sep 2025 is -10.60% vs 7.44% in Sep 2024

stock-summary

Standalone Net Profit

YoY Growth in quarter ended Sep 2025 is 12.03% vs -38.85% in Sep 2024

stock-summary

Operating Profit (PBDIT) excl Other Income

YoY Growth in quarter ended Sep 2025 is 11.70% vs -39.72% in Sep 2024

stock-summary

Interest

YoY Growth in quarter ended Sep 2025 is 29.41% vs -8.11% in Sep 2024

stock-summary

Operating Profit Margin (Excl OI)

YoY Growth in quarter ended Sep 2025 has improved from Sep 2024

Compare Quarterly Results Of Bayer CropSci. With
Markets Mojo
Figures in Cr
Standalone Quarterly Results
Markets Mojo
Markets Mojo
Change(INR)
Change(%)
Net Sales
1,553.40
914.44
638.96
69.87%
Other Operating Income
0.00
0.00
0.00
Total Operating income
1,553.40
914.44
638.96
69.87%
Raw Material Cost
715.90
449.41
266.49
59.30%
Purchase of Finished goods
102.10
70.72
31.38
44.37%
(Increase) / Decrease In Stocks
203.60
4.14
199.46
4,817.87%
Employee Cost
112.50
64.00
48.50
75.78%
Power Cost
0.00
0.00
0.00
Manufacturing Expenses
0.00
0.00
0.00
Selling and Distribution Expenses
0.00
0.00
0.00
Other Expenses
214.00
109.22
104.78
95.93%
Total Expenditure (Excl Depreciation)
1,348.10
697.49
650.61
93.28%
Operating Profit (PBDIT) excl Other Income
205.30
216.95
-11.65
-5.37%
Other Income
13.80
38.70
-24.90
-64.34%
Operating Profit (PBDIT)
219.10
255.65
-36.55
-14.30%
Interest
4.40
1.90
2.50
131.58%
Exceptional Items
0.00
0.00
0.00
Gross Profit (PBDT)
214.70
253.75
-39.05
-15.39%
Depreciation
14.40
15.87
-1.47
-9.26%
Profit Before Tax
200.30
237.87
-37.57
-15.79%
Tax
47.60
59.98
-12.38
-20.64%
Provisions and contingencies
0.00
0.00
0.00
Profit After Tax
152.70
177.90
-25.20
-14.17%
Extraordinary Items
0.00
0.00
0.00
Prior Period Expenses
0.00
0.00
0.00
Other Adjustments
0.00
0.00
0.00
Net Profit
152.70
177.90
-25.20
-14.17%
Equity Capital
44.90
499.15
-454.25
-91.00%
Face Value
10.00
10.00
0.00
Reserves
0.00
0.00
0.00
Earnings per share (EPS)
34.01
3.56
30.45
855.34%
Diluted Earnings per share
33.98
3.56
30.42
854.49%
Operating Profit Margin (Excl OI)
13.22%
23.72%
0.00
-10.50%
Gross Profit Margin
13.82%
27.75%
0.00
-13.93%
PAT Margin
9.83%
19.45%
0.00
-9.62%
Public Share Holdings (%)
0.00%
0.00%
0.00
0.00%
Pledged Promotor Holding (%)
0.00%
0.00%
0.00
0.00%
Quarterly - Net Sales
Net Sales 1,553.40 Cr
in Sep 2025

Figures in Cr
stock-summary

QoQ Growth in quarter ended Sep 2025 is -18.87% vs 82.97% in Jun 2025

stock-summary

YoY Growth in quarter ended Sep 2025 is -10.60% vs 7.44% in Sep 2024

Quarterly - Standalone Net Profit
Standalone Net Profit 152.70 Cr
in Sep 2025

Figures in Cr
stock-summary

QoQ Growth in quarter ended Sep 2025 is -45.21% vs 94.49% in Jun 2025

stock-summary

YoY Growth in quarter ended Sep 2025 is 12.03% vs -38.85% in Sep 2024

Quarterly - Operating Profit (PBDIT)
Operating Profit (PBDIT) 205.30 Cr
in Sep 2025

Figures in Cr
stock-summary

QoQ Growth in quarter ended Sep 2025 is -41.07% vs 103.98% in Jun 2025

stock-summary

YoY Growth in quarter ended Sep 2025 is 11.70% vs -39.72% in Sep 2024

Quarterly - Interest
Interest 4.40 Cr
in Sep 2025

Figures in Cr
stock-summary

QoQ Growth in quarter ended Sep 2025 is -6.38% vs -17.54% in Jun 2025

stock-summary

YoY Growth in quarter ended Sep 2025 is 29.41% vs -8.11% in Sep 2024

Quarterly - Operating Profit Margin (Excl OI)
Operating Profit Margin (Excl OI) 13.22%
in Sep 2025

Figures in %
stock-summary

QoQ Growth in quarter ended Sep 2025 has fallen from Jun 2025

stock-summary

YoY Growth in quarter ended Sep 2025 has improved from Sep 2024